Tower Research Capital LLC (TRC) - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$874,000
+1065.3%
4,027
+519.5%
0.02%
+650.0%
Q4 2020$75,000
-51.9%
650
-59.3%
0.00%0.0%
Q3 2020$156,000
-51.9%
1,598
-39.6%
0.00%
-84.6%
Q2 2020$324,0002,644
+88033.3%
0.01%
Q1 2020$03
+50.0%
0.00%
Q4 2019$0
-100.0%
2
-99.7%
0.00%
-100.0%
Q3 2019$69,000
-58.9%
597
-38.5%
0.01%
-54.5%
Q2 2019$168,000
+150.7%
971
+143.4%
0.01%
+175.0%
Q1 2019$67,000
-83.9%
399
-83.4%
0.00%
-87.1%
Q3 2018$416,000
+3681.8%
2,406
+2798.8%
0.03%
+3000.0%
Q4 2017$11,000
-75.0%
83
-80.8%
0.00%
-75.0%
Q3 2017$44,000
-39.7%
432
-40.3%
0.00%
-50.0%
Q2 2017$73,000
+114.7%
724
+159.5%
0.01%
+166.7%
Q1 2017$34,000
+54.5%
279
+44.6%
0.00%
+50.0%
Q4 2016$22,000
-68.1%
193
-62.7%
0.00%
-71.4%
Q3 2016$69,000
+331.2%
517
+127.8%
0.01%
+250.0%
Q1 2016$16,000
-54.3%
227
-40.1%
0.00%
-33.3%
Q3 2015$35,000
+400.0%
379
+531.7%
0.00%
+200.0%
Q2 2015$7,000
-92.6%
60
-94.2%
0.00%
-91.7%
Q1 2015$94,000
+1242.9%
1,029
+939.4%
0.01%
+1100.0%
Q4 2014$7,000
-89.1%
99
-87.5%
0.00%
-85.7%
Q3 2014$64,000
+36.2%
792
+81.7%
0.01%
+16.7%
Q2 2014$47,000
+235.7%
436
+79.4%
0.01%
+200.0%
Q1 2014$14,000
+133.3%
243
-65.4%
0.00%
Q2 2013$6,0007020.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders